Global Generic Drugs Market to 2028: Rising Occurrence of Chronic Medical Disorders Drives Growth

DUBLIN, April 25, 2023 /PRNewswire/ -- The "Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering.

The global generic drugs market size reached US$ 343.6 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 460.5 Billion by 2028, exhibiting a CAGR of 5% during 2022-2028.

Companies Mentioned

• Teva Pharmaceuticals Industries Ltd.
• Mylan N.V.
• Novartis AG
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Fresenius SE & Co.
• Lupin Limited
• Endo Pharmaceuticals Inc.
• Aurobindo Pharma Limited
• Aspen Pharmacare Holdings Limited

Generic drugs are bioequivalent of branded medicines with the same active ingredients and equivalent therapeutic effects. They also have similar dosages, risks, consequences, side effects, strengths, intended use, and route of administration. They are relatively less expensive than branded drugs, as the production does not require extensive research.

Besides this, the production of these drugs does not involve the repetition of clinical and animal studies to measure the effectiveness and safety of the medicine. As a result, generic drugs are gaining immense traction across the globe.

The growing global geriatric population and the rising occurrence of chronic medical disorders, such as cancer, diabetes, and cardiovascular diseases, represent one of the key factors positively influencing the market. In addition, changing dietary patterns and hectic schedules of individuals are leading to various conditions, which, in turn, is catalyzing the demand for generic drugs worldwide.

Along with this, increasing efforts by governments of various countries to reduce healthcare costs and promote the manufacturing and uptake of generics are contributing to the market growth. They are also encouraging key players to introduce effective generic drugs and provide easy availability.

Apart from this, the low production cost of generic medicines is creating a positive outlook for the market. Additionally, the expansion of the pharma companies and medical stores across the globe is further augmenting the market growth.

Furthermore, the rising focus of leading manufacturers on partnership strategies to launch new products is propelling the market growth. Moreover, increasing investments in extensive research and development (R&D) activities and technological advancements in medicine formulation are anticipated to drive the market.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global generic drugs market report, along with forecasts at the global and country level from 2023-2028. Our report has categorized the market based on therapy area, drug delivery, and distribution channel.

Breakup by Therapy Area:

• Central Nervous System
• Cardiovascular
• Dermatology
• Genitourinary/Hormonal
• Respiratory
• Rheumatology
• Diabetes
• Oncology
• Others

The central nervous system (CNS) represents the leading therapy area due to the rising prevalence of brain and spinal cord ailments across the globe.

Breakup by Drug Delivery:

• Oral
• Injectables
• Dermal/Topical
• Inhalers

Oral medicines are the most preferred form of drug delivery due to their convenient administration, which requires minimal to no medical assistance.

Breakup by Distribution Channel:

• Retail Pharmacies
• Hospital Pharmacies

Presently, the majority of generic drugs are distributed through retail pharmacy stores as most generic medications are over-the-counter (OTC) medicines and require no prescription.

Breakup by Country:

• United States
• China
• Brazil
• Germany
• France
• India
• United Kingdom
• Japan
• Canada
• Italy
• Others

The United States exhibits a clear dominance in the market on account of numerous initiatives undertaken by governing authorities to improve generic drug manufacturing and access in the country.

Key Questions Answered in This Report
1. What was the size of the global generic drugs market in 2022?
2. What is the expected growth rate of the global generic drugs market during 2023-2028?
3. What are the key factors driving the global generic drugs market?
4. What has been the impact of COVID-19 on the global generic drugs market?
5. What is the breakup of the global generic drugs market based on the therapy area?
6. What is the breakup of the global generic drugs market based on the drug delivery?
7. What is the breakup of the global generic drugs market based on the distribution channel?
8. What are the key regions in the global generic drugs market?
9. Who are the key players/companies in the global generic drugs market?

For more information about this report visit https://www.researchandmarkets.com/r/armbot

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets